1
Participants
Start Date
August 23, 2022
Primary Completion Date
November 15, 2022
Study Completion Date
December 13, 2022
Namilumab
Specified dose on specified days
Kinevant Study Site, New York
Kinevant Study Site, Baltimore
Kinevant Study Site, Charleston
Kinevant Study Site, Gainesville
Kinevant Study Site, Cleveland
Kinevant Study Site, Ann Arbor
Kinevant Study Site, Iowa City
Kinevant Study Site, Denver
Kinevant Study Site, Palo Alto
Kinevant Study Site, Portland
Kinevant Study Site, New Haven
Kinevant Study Site, Boston
Lead Sponsor
Kinevant Sciences GmbH
INDUSTRY